G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5 | -54.5% | 2,026 | 0.0% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 2,026 | -11.0% | 0.00% | – |
Q1 2022 | $18,000 | -21.7% | 2,277 | 0.0% | 0.00% | – |
Q4 2021 | $23,000 | -25.8% | 2,277 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | -38.0% | 2,277 | 0.0% | 0.00% | – |
Q2 2021 | $50,000 | -7.4% | 2,277 | 0.0% | 0.00% | – |
Q1 2021 | $54,000 | +31.7% | 2,277 | 0.0% | 0.00% | – |
Q4 2020 | $41,000 | +57.7% | 2,277 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | -52.7% | 2,277 | 0.0% | 0.00% | – |
Q2 2020 | $55,000 | +120.0% | 2,277 | 0.0% | 0.00% | – |
Q1 2020 | $25,000 | -58.3% | 2,277 | 0.0% | 0.00% | – |
Q4 2019 | $60,000 | -25.0% | 2,277 | -12.8% | 0.00% | – |
Q2 2019 | $80,000 | +86.0% | 2,612 | 0.0% | 0.00% | – |
Q1 2019 | $43,000 | -10.4% | 2,612 | 0.0% | 0.00% | – |
Q4 2018 | $48,000 | -65.0% | 2,612 | 0.0% | 0.00% | – |
Q3 2018 | $137,000 | +21.2% | 2,612 | 0.0% | 0.00% | – |
Q2 2018 | $113,000 | +189.7% | 2,612 | +148.3% | 0.00% | – |
Q1 2018 | $39,000 | +85.7% | 1,052 | 0.0% | 0.00% | – |
Q4 2017 | $21,000 | – | 1,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |